Metabolomics market

Metabolomics Services Market, by Service Type (Targeted Metabolomics Service, Untargeted Metabolomics Service), by Technique (Detection Techniques (Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS)), Separation Techniques (Gas Chromatography (GC), Capillary Electrophoresis (CE), Liquid Chromatography (LC), Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)), by Application (Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others (Crop Breeding, Disease Diagnosis, etc.)), by End User (Academics and Research Labs, Biotechnology and Pharmaceutical Companies, and Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Dec 2022
CMI180
256 Pages
Excel & Pdf
Clinical Diagnostic

Summary

Metabolomics is the systematic identification and quantitation of all metabolites in a given organism or biological sample. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), provide the enhanced resolution, along with the powerful chemometric software, that allows the simultaneous determination and comparison of thousands of chemical entities, which has lead to an expansion of small molecule biochemistry studies in bacteria, plants, and mammals. Targeted and untargeted metabolomics service are the two major types of metabolomics services.

The global metabolomics services market is estimated to be valued at US$ 483.74 million in 2022 and is expected to exhibit a CAGR of 14.2% during the forecast period (2022-2030).

Figure 1. Global Metabolomics Services Market Share (%), by Service Type, 2022

Global Metabolomics Services Market - Drivers

Adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, in June 2021, Thermo Fisher Scientific Inc., a manufacturer of analytical instruments, announced that they had launched Orbitrap IQ-X Tribrid mass spectrometer which enables confident structure elucidation and unknown analytes identification. The wide range applications of Orbitrap IQ-X Tribrid mass spectrometer include metabolomics and lipidomics research, leachable impurities identification, and forensic toxicology.

Metabolomics Services Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 483.74 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	14.2%	2030 Value Projection:	US$ 1,396.79 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Service Type: Targeted Metabolomics Service, Untargeted Metabolomics Service By Technique: Detection Techniques (Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS)), Separation Techniques (Gas Chromatography (GC), Capillary Electrophoresis (CE), Liquid Chromatography (LC), Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)) By Application: Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others (Crop Breeding, Disease Diagnosis, etc.) By End User: Academics and Research Labs, Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories
Companies covered:	Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.
Growth Drivers:	Increasing adoption of inorganic strategies such as product launches by key market players
Restraints & Challenges:	Various challenges associated with the metabolomics such as sample collection, processing, and laboratory analysis phases, etc.

Figure 2. Global Metabolomics Services Market Share (%), by Region, 2022

Global Metabolomics Services Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global metabolomics services market. For instance, in March 2021, according to the data published in article Nature, by using the application targeted and untargeted metabolomics with gas chromatography-mass spectrometry (GC-MS) and ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC-MS) on plasma samples of patients were diagnosed with SARS-CoV-2 infection and compared to 27 ambulatory patients with flu-like symptoms, negative for COVID-19. Thus, 77 metabolites exhibited stage-dependent alterations in their plasma concentration. From these metabolites, 57 were increased in critical care patients and among 30 metabolites, 29 were higher and 1 lower in critical than in mild cases.

Global Metabolomics Services Market: Key Developments

Increasing adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global metabolomics services market growth over the forecast period. For instance, in June 2022, Shimadzu Corporation, a medical equipment company, announced that they had launched LCMS-2050 high-performance liquid chromatograph mass spectrometer, which is used to discover the presence or absence of impurities in the pharmaceutical and chemical fields, and for the confirmation of synthetic products and measurement of the amounts of ingredients in food products.

Global Metabolomics Services Market: Restraint

Various challenges associated with the metabolomics is expected to hinder the global metabolomics market over the forecast period. For instance, according to an article published in national library of medicine, in January 2019, challenges typically arise during the sample collection, processing, and laboratory analysis phases. The type of specimen, collection method, storage conditions, and profiling-related variables such as analytical batch can impact metabolomic profiles and add noise to the data.

Global Metabolomics Services Market - Key Players

Major players operating in the global metabolomics services market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.

Table of Content

Table of Contents

*Browse 44 market data tables and 36 figures on "Global Metabolomics Services Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global metabolomics services market during the forecast period (2022-2030)?

The global metabolomics services market is estimated to be valued at US$ 483.74 million in 2022 and is expected to exhibit a CAGR of 14.2% between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as increasing adoption of inorganic growth strategies such as product launches by key market players are expected to drive the market growth.

Which is the leading service type segment in the market?

Untargeted metabolomics service is the leading service type segment in the market

What are the key factors hampering the growth of the market?

Various challenges associated with the metabolomicssuch as sample collection, processing, and laboratory analysis phases, etc. is expected to hamper the market.

Which are the major players operating in the market?

Major players operating in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.